Hemophilia Strategic Partnership Lead

Hemophilia Strategic Partnership Lead - Korea, Republic of - Seoul

Full time

Posted 1 Days Ago

4961555

Our Purpose

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

Explore our mission

Our Values

To fully realize Pfizer’s purpose – Breakthroughs that change patients’ lives – we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

Learn our four core values

Benefits

• Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

• Read about our benefits

• Pfizer, We are one

• Position Summary

• The Hemophilia Strategic Partnership Lead is a senior commercial role responsible for the growth and long-term sustainability of Pfizer Korea’s hemophilia portfolio. Reporting to the Strategic Alliance & Partnership (SA&P) Lead, the role drives Pfizer’s commercial strategy and stakeholder engagement across the hemophilia landscape in Korea.

• The role pairs strategic thinking with strong field execution — building a deep understanding of the Hemophilia A landscape, developing key-account engagement strategy, and strengthening the stakeholder relationships that support a sustainable business. As Pfizer’s Hemophilia A market expert, the successful candidate translates field insight into clear commercial direction and works cross-functionally to deliver an integrated portfolio approach.

• Main Responsibilities / Duties

• 1. Hemophilia A Market Navigation & Stakeholder Insight

• Build and maintain a deep, current understanding of the Korea Hemophilia A landscape — hemophilia treatment centers (HTCs), prescriber decision drivers, prophylaxis paradigms, and the positioning of factor and non-factor therapies (including the incumbent emicizumab franchise).

• Develop and own a prioritized stakeholder map of high-value Hemophilia A accounts, key opinion leaders, hospital pharmacy and procurement decision-makers, and institutional stakeholders such as the Korea Hemophilia Foundation (KHF).

• Generate structured field intelligence on competitive dynamics, switching behavior, and unmet need, and translate it into decision-ready input for brand strategy and forecasting.

• 2. Key Account Penetration Strategy

• Design and execute account-level penetration plans for priority Hemophilia A centers, defining the clinical and economic value levers that drive adoption and differentiate Pfizer in target accounts.

• Establish account-specific engagement and access roadmaps aligned to the brand strategy and the Korean reimbursement (HIRA) environment.

• Sequence engagement to accelerate early uptake and protect against competitive entrenchment in target accounts.

• 3. Strategic Alliance & Business Model Development

• Identify and assess potential external partnership opportunities that may support portfolio strategy, stakeholder engagement, and sustainable business objectives, using field insight to inform the business rationale and appropriate engagement model.

• Build transparent, compliant, and purpose-driven engagements with key institutions, academic societies, and clinical opinion leaders, including the Korea Hemophilia Foundation where appropriate, while respecting stakeholder independence and ensuring a legitimate patient, scientific, educational, or access-related purpose.

• Shape the partnership operating model — governance and ways of working — so that it is sustainable, effective, and fully compliant with Pfizer policy and Korean regulation.

• Convert field insight into recommendations on go-to-market design, the optimal commercial model, and launch sequencing and investment decisions toward the Hemophilia A winning choice.

• Partner with Marketing, Market Access, Medical, and Sales to deliver an integrated portfolio narrative across Hemophilia A and B.

• 4. Strategic Leadership & Influence

• Act as the recognized Hemophilia A subject-matter authority within SA&P and the broader Korea commercial organization.

• Influence cross-functional teams and senior stakeholders without direct authority — bringing a strategist’s framing and a builder’s drive to execution.

• Role-model Pfizer’s values (Courage, Excellence, Equity, Joy) and an enterprise, One-Pfizer mindset.

• Required Skill Set

Education

• Bachelor’s degree required.

Experience

• Minimum 8–10 years of pharmaceutical commercial experience, with a substantial track record in Hemophilia — or directly transferable rare-disease / specialty hematology — market development.

• Demonstrable depth of understanding and credibility with Hemophilia treaters, treatment centers, and the broader hemophilia community in Korea.

• Proven success in key account management and in the launch or market development of a specialty / rare-disease product.

• Experience managing and supporting third-party alliances, co-promotion, or partnership models.

• Knowledge

• Strong command of the Korean hemophilia treatment and reimbursement environment (HIRA criteria) and the competitive landscape across factor and non-factor therapies.

• Working understanding of institutional stakeholder dynamics, HTC operations, and the role of organizations such as the Korea Hemophilia Foundation (KHF).

• Competencies

• Strategic thinking paired with strong executional drive — able to design the plan and personally move it forward when execution lags.

• Stakeholder engagement and relationship-building, with high trust and executive presence.

• Analytical rigor and the ability to synthesize ambiguous field signals into clear, decision-ready insight.

• Cross-functional collaboration and influence within a matrixed organization.

• Business acumen, negotiation skill, and a disciplined compliance mindset.

• Travel & Working Conditions

• Field-based role requiring frequent nationwide travel to priority accounts and partner organizations.

• Work

Location

Assignment: Hybrid

• Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.

• To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers.

Marketing and Market Research

Breakthroughs that change patients’ lives

Research confirms what intuition tells us: that purpose-driven companies perform better, are more innovative, attract and retain the best people, and know how to unleash the power of those people. Pfizer’s purpose—Breakthroughs that change patients' lives—fuels everything we do and reflects our passion for building on our legacy as one of the greatest contributors of good to the world.

Each word in our purpose has meaning and reflects the value we strive to bring to patients and society:

• “Breakthroughs” - These are the innovations, scientific and commercial, that we seek to deliver every day. All colleagues, regardless of role, level or location, strive for breakthroughs every day.

• “Change” - We want to do more than simply improve patients’ medical conditions; we want to dramatically change their lives for the better.

• “Patients’ lives” - We consider not only patients, but everyone they touch—including their families, caregivers, and friends—and everything they love to do. It’s an intentionally holistic view.

• Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.

• Every decision we make and every action we take is done with the patient in mind—and to nurture an environment where breakthroughs can thrive.

Our Values

To fully realize Pfizer’s purpose, we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

The “how” is represented by four simple, powerful values—courage, excellence, equity, and joy—that define our company and our culture.

• Courage: Breakthroughs start by challenging convention, especially in the face of uncertainty or adversity. This happens when we think big, speak up, and are decisive.

• Excellence: We can only change patients’ lives when we perform at our best together. This happens when we focus on what matters, agree who does what, and measure our outcomes.

• Equity: We believe that every person deserves to be seen, heard, and cared for. This happens when we are inclusive, act with integrity, and reduce healthcare disparities.

• Joy: We give ourselves to our work, but it also gives to us. We find joy when we take pride, recognize one another, and have fun.

Benefits at Pfizer

Pfizer offers competitive compensati